Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 11, Issue 4, Pages 309
Publisher
MDPI AG
Online
2021-04-16
DOI
10.3390/jpm11040309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High levels of gut-homing immunoglobulin A–positive+B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients
- (2020) Fabio Sallustio et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice
- (2019) Lianjun Yang et al. Frontiers in Cellular and Infection Microbiology
- Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
- (2019) Dita Maixnerova et al. PLoS One
- IgA nephropathy: “State of the art”: a report from the 15th International Symposium on IgA Nephropathy celebrating the 50th anniversary of its first description
- (2019) Hernán Trimarchi et al. KIDNEY INTERNATIONAL
- B cell activation factor (BAFF) induces inflammation in the human fallopian tube leading to tubal pregnancy
- (2019) Jianying Xu et al. BMC Pregnancy and Childbirth
- SaO041Soluble CD89-IgA1 complexes and galactose deficient-IgA1 are biomarkers associated with histologic inflammation in children IgA nephropathy
- (2019) Alexandra Cambier et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Characteristics of Intestinal-barrier Damage in Rats with IgA Nephropathy
- (2019) Nan Zhou et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Microbiome modulation to correct uremic toxins and to preserve kidney functions
- (2019) Gianvito Caggiano et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- A New Vision of IgA Nephropathy: The Missing Link
- (2019) Fabio Sallustio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases
- (2018) Jasmohan S. Bajaj et al. DIGESTIVE AND LIVER DISEASE
- The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease
- (2018) Loris R. Lopetuso et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota
- (2018) Yu Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Recent advances in the physiopathology of IgA nephropathy
- (2018) Renato C. Monteiro Nephrologie & Therapeutique
- Insights into the Role of Mucosal Immunity in IgA Nephropathy
- (2018) Yue-miao Zhang et al. Clinical Journal of the American Society of Nephrology
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
- (2017) Jicheng Lv et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Intricate Link among Gut “Immunological Niche,” Microbiota, and Xenobiotics in Intestinal Pathology
- (2017) Danilo Pagliari et al. MEDIATORS OF INFLAMMATION
- Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
- (2017) Francesca Romana Ponziani et al. WORLD JOURNAL OF GASTROENTEROLOGY
- IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy
- (2016) S. M. Lechner et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Gluten exacerbates IgA nephropathy in humanized mice through gliadin–CD89 interaction
- (2015) Christina Papista et al. KIDNEY INTERNATIONAL
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- (2015) Thomas Rauen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
- (2014) Maria De Angelis et al. PLoS One
- SOCS3 Regulates BAFF in Human Enterocytes under Ribosomal Stress
- (2013) K. H. Do et al. JOURNAL OF IMMUNOLOGY
- Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
- (2012) Laureline Berthelot et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathy
- (2011) Douglas D. McCarthy et al. JOURNAL OF CLINICAL INVESTIGATION
- The Pathophysiology of IgA Nephropathy
- (2011) H. Suzuki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Regulation of the polymeric immunoglobulin receptor by the classical and alternative NF-κB pathways in intestinal epithelial cells
- (2011) M E C Bruno et al. Mucosal Immunology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started